Serogroup B Meningococcal Outer Membrane Vesicle Vaccine
Classification:
Products in the Pipeline
- Product Description
- Immunogenicity
- Security
- Mad Dog Bite Cases
-
Manufacturing Process
It employs leading Outer-Membrane Vesicle (OMV) technology in China as an international cooperation project of CDBIO with the more advanced design and higher immunogenicity.
Current Progress
In pre-clinical study.
Previous Page
Other Products